Tibolone and Endometrial Cancer
- 1 January 2005
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 28 (3), 241-249
- https://doi.org/10.2165/00002018-200528030-00005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Utilisation of hormone replacement therapy in the United KingdomBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Estrogenic effects of 7α-methyl-17α-ethynylestradiol: a newly discovered tibolone metaboliteSteroids, 2002
- Formation of 7??-methyl-ethinyl estradiol during treatment with tiboloneMenopause, 2002
- Impact on Uterine Bleeding and Endometrial Thickness: Tibolone Compared with Continuous Combined Estradiol and Norethisterone Acetate Replacement TherapyMenopause, 1999
- The effects of tiboloneGynecological Endocrinology, 1998
- Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacment therapyMaturitas, 1995
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125BJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Endometrial hyperplasia and adenocarcinoma during tibolone (Livial®) therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- The incidence of vaginal bleeding with tibolone treatmentBJOG: An International Journal of Obstetrics and Gynaecology, 1994